Literature DB >> 11786713

Natural killer cell activity in multidrug-resistant pulmonary tuberculosis.

P Yildiz1, F Kadakal, Y Tütüncü, G Deniz, N Gürel, S Adin, V Yilmaz.   

Abstract

BACKGROUND: Multidrug-resistant pulmonary tuberculosis (MDRTB), a major problem in developing countries, may result from either insufficiency of host cellular immune response or mycobacterial mechanisms which has been more intensively investigated so far.
OBJECTIVES: The aim of the study was to investigate natural killer cell activity (NKA) and T lymphocyte subsets in HIV- patients with secondary MDRTB.
METHODS: 20 male patients with MDRTB (mean age 38 +/- 8 years), 15 nonresistant tuberculosis male patients (NRTB) (mean age 36 +/- 11 years) and 12 healthy male controls (mean age 35 +/- 8 years) were included. The percentages of CD3+, CD4+, CD8+, CD25+, CD11b+ and CD16+56+ cells were measured by flow-cytometric analysis of peripheral blood lymphocytes (PBL). NKA was evaluated using the anticandidal index method.
RESULTS: The mean tuberculin response was higher in MDRTB and NRTB patients compared to controls (15.4 +/- 3.8, 15.1 +/- 3.3 and 10.9 +/- 2.8 mm, respectively; p < 0.001). There was no significant correlation between PPD response and PBL subsets or NKA. The percentages of both CD3+ and CD3+CD4+ T lymphocytes were significantly lower in MDRTB (62.4 +/- 12.1 and 33.9 +/- 9.0%) compared to NRTB (70.8 +/- 7.5 and 42.9 +/- 8.6%; p < 0.05). Patients with MDRTB had significantly lower NKA compared to NRTB and controls (30.9 +/- 11.3, 49.7 +/- 15.5 and 40.0 +/- 8.5%, respectively; p < 0.01).
CONCLUSION: This reduction in NKA may suggest a role for impaired NK function in the pathogenesis of MDRTB in HIV- patients. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11786713     DOI: 10.1159/000050577

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  4 in total

1.  Can immune parameters be used as predictors to distinguish between pulmonary multidrug-resistant and drug-sensitive tuberculosis?

Authors:  Bayram Kiran; Tulin Cagatay; Philip Clark; Filiz Kosar; Penbe Cagatay; Sibel Yurt; Faruk Suzergoz; Ali Osman Gurol
Journal:  Arch Med Sci       Date:  2010-03-09       Impact factor: 3.318

2.  Lymphocyte subpopulations in pulmonary tuberculosis patients.

Authors:  Figen Deveci; H Handan Akbulut; Ilhami Celik; M Hamdi Muz; Fulya Ilhan
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

Review 3.  The CD4+/CD8+ Ratio in Pulmonary Tuberculosis: Systematic and Meta-Analysis Article.

Authors:  Yongmei Yin; Jie Qin; Yaping Dai; Fanwei Zeng; Hao Pei; Jun Wang
Journal:  Iran J Public Health       Date:  2015-02       Impact factor: 1.429

4.  Association of Immune Factors with Drug-Resistant Tuberculosis: A Case-Control Study.

Authors:  En-Tao Sun; Dan Xia; Ben-He Li; Jun Ma; Yuan-Yuan Dong; Shu-Shu Ding; Bai-Feng Chen; Yu-Feng Wen
Journal:  Med Sci Monit       Date:  2017-11-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.